Received Feb 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | J4K4X | — |
A 45 years old female patient received a pediatric dose of Havrix.; underdose; This non-serious case was reported by a other health professional via call center representative and described the occurrence of adult use of a child product in a 45-year-old female patient who received HAV (Havrix pediatric) (batch number J4K4X, expiry date 28-DEC-2026) for prophylaxis. On an unknown date, the patient received Havrix pediatric. On an unknown date, an unknown time after receiving Havrix pediatric, the patient experienced adult use of a child product (Verbatim: A 45 years old female patient received a pediatric dose of Havrix.) and underdose (Verbatim: underdose). The outcome of the adult use of a child product and underdose were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 20-FEB-2025 The health care professional reported that they administered a pediatric dose of Havrix to a 45 years old female patient, which led to adult use of a child product and underdose. The reporter was ask what is the protocol to follow.